Held at Seminar Room AC-7-10, at the Academia, from 12.30 pm to 1.30 pm on 17 August, this Guest Speaker Series seminar will feature Prof Matthias von Herrath from La Jolla Institute who will share his findings on autoreactive and bystander cells in diabetes.

Local institutions partner in largest heart failure study in Singapore

In the largest heart failure study, researchers from 11 local institutes, including Duke-NUS and the National Heart Centre Singapore (NHCS), will collaborate to learn more about heart failure in Singapore. Led by Associate Professor Carolyn Lam from NHCS, this multi-agency collaboration will pool together the expertise of doctors and researchers.

The next pre-proposal submission for the Innovation to Develop (I2D) grant by National Health Innovation Centre (NHIC) will close on 25 September. The grant aims to fund innovations that have strong intellectual property positions and will benefit the healthcare sector significantly.

To foster translational and clinical research for diseases prevalent in Asia, SingHealth Duke-NUS Academic Medical Centre and the National University Health System (NUHS) will be collaborating with Bayer Healthcare. Particularly, these collaborations will focus on expanding existing research on heart and eye diseases, and cancer treatment.

Did you know that doctors are now able to predict the relapse rate for liver cancer patients who have undergone surgery? Developed by doctors at the National Cancer Centre Singapore (NCCS) and Singapore General Hospital (SGH), the Singapore Liver Cancer Recurrence (SLICER) Score may be used to guide patient counselling.

Researchers from Duke-NUS bring the development of a “drug cocktail” closer to reality, after discovering why some dengue strains are more likely to lead to epidemics than others. Dengue is difficult to fight as the virus has four serotypes.Researchers have found an antibody that could neutralise Serotype 2.